PATENT CLAIM ANALYSIS

Application Number: 15769864
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "016600"]

Abstract:
The present invention relates to amino acid sequences that are directed against IL-23. The amino acid sequences of the present invention comprise two Nanobodies against IL-23 and one Nanobody against serum albumin, linked by two linkers (9GS linkers). In particular, the invention relates to the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 3 (listed in Table 1 and FIG.  1 ) (also referred to herein as “anti-IL 23 polypeptides of the invention”).

Claim (Index 2):
Polypeptide comprising the amino acid sequence of SEQ ID NO: 2.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 91.0
- Lexical Diversity: 1.73585
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15501011', '15456824', '15317188', '14922630', '15317633']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6968675460148333
- 35 USC 102 Novelty (BERT): 0.5088533880522512
- Combined Prediction Score: 0.6780661302185751
- Mean Citation Score: 187.13611
- Max Citation Score: 195.08955
- Similarity Product: 116.84936827482284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test